Spleen, primary malignancy: Difference between revisions
Ttenbergen (talk | contribs) m adding {{Data Integrity Check List}} |
No edit summary |
||
| Line 1: | Line 1: | ||
{{ICD10 transition status | {{ICD10 transition status | ||
| OldDxArticle = | | OldDxArticle = | ||
| CurrentStatus = | | CurrentStatus = reconciled | ||
| InitialEditorAssigned = Con Marks | | InitialEditorAssigned = Con Marks | ||
}} | }} | ||
| Line 12: | Line 12: | ||
== Additional Info == | == Additional Info == | ||
*Tumors of the spleen are rare compared to the incidence of such tumors in other parenchymatous organs. They can be divided into two main categories: nonlymphoid and lymphoid. The most common nonlymphoid tumors are the vascular tumors which include benign and malignant haemangiomas, littoral cell angiomas, lymphangiomas and haemangioendotheliomas. The remaining nonlymphoid tumors, such as fibrosarcoma, neurinoma, and lipoma are very uncommon. The lymphoid tumors include Hodgkin’s and non Hodgkin’s lymphoma, histiocytic lymphoma and plasmacytoma. | |||
{sc:Hodgkin's disease, non-Hodgkin's lymphoma} | {sc:Hodgkin's disease, non-Hodgkin's lymphoma} | ||